-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Buy on Astrana Health, Lowers Price Target to $46

Benzinga·03/18/2025 14:05:59
Listen to the news
Truist Securities analyst Jailendra Singh maintains Astrana Health (NASDAQ:ASTH) with a Buy and lowers the price target from $50 to $46.